THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNOR UNIV has a total of 13 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2012. It filed its patents most often in Canada and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and computer technology are ASS FR CONTRE LES MYOPATHIES, THE CHILDREN'S HOSPITAL OF PHILADELPHIA and CHILDRENS HOSPITAL PHILADELPHIA.
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Computer technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes | |
#5 | Bioinformatics | |
#6 | Analysing materials | |
#7 | Peptides | |
#8 | Computational chemistry | |
#9 | Healthcare informatics | |
#10 | Image data processing |
# | Name | Total Patents |
---|---|---|
#1 | Alizadeh Arash Ash | 2 |
#2 | Newman Aaron M | 2 |
#3 | Mendoza Juan Luis | 1 |
#4 | Rabinovitch Marlene | 1 |
#5 | Ramakrishnan Charu | 1 |
#6 | Deisseroth Karl A | 1 |
#7 | Kowarsky Mark Alec | 1 |
#8 | Solow-Cordero David | 1 |
#9 | Zaleta Katheia M Rivera | 1 |
#10 | Mackall Crystal | 1 |
Publication | Filing date | Title |
---|---|---|
CN107430588A | For the method and system for the ratio for determining different cell subsets | |
CA2938084A1 | Oligonucleotides and methods for treatment of cardiomyopathy using rna interference |